832 WRF 4 (Jantoven 4 mg)
Generic Name: warfarin
Pill imprint 832 WRF 4 has been identified as Jantoven 4 mg.
Jantoven is used in the treatment of deep vein thrombosis, first event; prevention of thromboembolism in atrial fibrillation; pulmonary embolism, recurrent event; pulmonary embolism, first event; thromboembolic stroke prophylaxis (and more), and belongs to the drug class coumarins and indandiones. For women with mechanical heart valves: There is positive evidence of human fetal risk during pregnancy. For other pregnant populations: Not for use in pregnancy. Jantoven 4 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- 832 WRF 4
- 4 mg
- 9.00 mm
- Prescription only
- Drug Class:
- Coumarins and indandiones
- Pregnancy Category:
- D - Positive evidence of risk - for women with mechanical heart valves
X - Not for use in pregnancy - for other pregnant populations
- CSA Schedule:
- Not a controlled drug
- Upsher-Smith Laboratories, Inc
- National Drug Code (NDC):
- Inactive Ingredients:
- lactose monohydrate
FD&C Blue No. 1
|NDC Code||Manufacturer / Repackager|
|54868-0825||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Jantoven (warfarin)
- Other brands: Coumadin
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.